J1455 HCPCS Level II code: Injection, foscarnet sodium, per 1000 mg
J1455 is the HCPCS code for “Injection, foscarnet sodium, per 1000 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1455Injection, foscarnet sodium, per 1000 mg
Short description: Foscarnet sodium injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J1455 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1993
Where J1455 sits
- 1J codesDrugs administered other than orally
- 2Active code J1455Injection, foscarnet sodium, per 1000 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1455 mean?
J1455 is the HCPCS code for “Injection, foscarnet sodium, per 1000 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1455?
CMS lists J1455’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1455
All J codesJ1449Injection, eflapegrastim-xnst, 0.1 mgJ1450Injection fluconazole, 200 mgJ1451Injection, fomepizole, 15 mgJ1452Injection, fomivirsen sodium, intraocular, 1.65 mgJ1453Injection, fosaprepitant, 1 mgJ1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mgJ1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mgJ1457Injection, gallium nitrate, 1 mgJ1458Injection, galsulfase, 1 mgJ1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mgJ1460Injection, gamma globulin, intramuscular, 1 ccJ1551Injection, immune globulin (cutaquig), 100 mg